Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Advances in Therapy
|
March 26, 2021
Cost-Effectiveness Analysis of Adding Daratumumab to a Regimen of Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma
Xiaohui Zeng, Qiao Liu, Liubao Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2025
The integrated stress response suppresses antiviral RNA interference by autophagy-mediated degradation of the RNA-induced silencing complex
Qiyu Wang, Lingyue Chen, Jiayin Wang, et al.
Journal of Agricultural and Food Chemistry
|
December 31, 2024
Dynamic Lipidomics and Transcriptome Profiling Reveals the Transcriptional Regulatory Mechanism Governing TAGs Formation in Seeds of Safflower
Dandan Li, Xiaohui Zeng, Yao Wu, et al.
Frontiers in Pharmacology
|
June 17, 2022
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer
Meiyu Wu, Shuxia Qin, Liting Wang, et al.
Clinical Therapeutics
|
January 19, 2013
Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system
Xiaohui Zeng, Liubao Peng, Jianhe Li, et al.
Plos One
|
March 4, 2014
Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis
Xiaohui Zeng, Jianhe Li, Liubao Peng, et al.
Frontiers in Pharmacology
|
September 13, 2021
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
Xiaomin Wan, Xiaohui Zeng, Liubao Peng, et al.
Clinical Rheumatology
|
August 10, 2021
Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis
Chongqing Tan, Xia Luo, Sini Li, et al.
Chemical Science
|
September 17, 2025
Dynamic networks of fluorine-rich acrylates enable highly conductive and flame-retardant electrolytes for lithium metal batteries
Junyi Gan, Yao Zhao, Zhan Jiang, et al.
Plos One
|
December 17, 2013
Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China
Chongqing Tan, Liubao Peng, Xiaohui Zeng, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Advances in Therapy
|
March 26, 2021
Cost-Effectiveness Analysis of Adding Daratumumab to a Regimen of Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma
Xiaohui Zeng, Qiao Liu, Liubao Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2025
The integrated stress response suppresses antiviral RNA interference by autophagy-mediated degradation of the RNA-induced silencing complex
Qiyu Wang, Lingyue Chen, Jiayin Wang, et al.
Journal of Agricultural and Food Chemistry
|
December 31, 2024
Dynamic Lipidomics and Transcriptome Profiling Reveals the Transcriptional Regulatory Mechanism Governing TAGs Formation in Seeds of Safflower
Dandan Li, Xiaohui Zeng, Yao Wu, et al.
Frontiers in Pharmacology
|
June 17, 2022
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer
Meiyu Wu, Shuxia Qin, Liting Wang, et al.
Clinical Therapeutics
|
January 19, 2013
Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system
Xiaohui Zeng, Liubao Peng, Jianhe Li, et al.
Plos One
|
March 4, 2014
Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis
Xiaohui Zeng, Jianhe Li, Liubao Peng, et al.
Frontiers in Pharmacology
|
September 13, 2021
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
Xiaomin Wan, Xiaohui Zeng, Liubao Peng, et al.
Clinical Rheumatology
|
August 10, 2021
Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis
Chongqing Tan, Xia Luo, Sini Li, et al.
Chemical Science
|
September 17, 2025
Dynamic networks of fluorine-rich acrylates enable highly conductive and flame-retardant electrolytes for lithium metal batteries
Junyi Gan, Yao Zhao, Zhan Jiang, et al.
Plos One
|
December 17, 2013
Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China
Chongqing Tan, Liubao Peng, Xiaohui Zeng, et al.
Page
of 13